切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2022, Vol. 11 ›› Issue (05) : 367 -371. doi: 10.3877/cma.j.issn.2095-3224.2022.05.003

侧方淋巴结清扫专栏

直肠癌侧方淋巴结清扫中国临床开展的现状
刘骞1,()   
  1. 1. 100021 北京,国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院结直肠外科
  • 收稿日期:2022-09-14 出版日期:2022-10-25
  • 通信作者: 刘骞
  • 基金资助:
    国家重点研发计划“重大慢性非传染性疾病防控研究”重点专项(2019YFC1315705); 中国癌症基金会北京希望马拉松专项基金(LC2017L07)

The clinical status of lateral lymph node dissection for rectal cancer in China

Qian Liu1,()   

  1. 1. Department of Colorectal Surgery, National Cancer Center /National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Received:2022-09-14 Published:2022-10-25
  • Corresponding author: Qian Liu
引用本文:

刘骞. 直肠癌侧方淋巴结清扫中国临床开展的现状[J]. 中华结直肠疾病电子杂志, 2022, 11(05): 367-371.

Qian Liu. The clinical status of lateral lymph node dissection for rectal cancer in China[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2022, 11(05): 367-371.

尽管目前东西方对于直肠癌侧方淋巴结清扫仍存争议,但中国学术界依据现有的循证医学证据制定了符合中国国情的侧方淋巴结清扫相关共识、指南和规范。相较于日本,国内侧方淋巴结清扫指征把握更加严格,仅当有明确影像学证据疑诊存在侧方淋巴结转移时,才会选择性进行清扫,常规清扫区域也仅限于髂内和闭孔周围。基于全面了解盆腔解剖结构的前提下,以筋膜为导向的两间隙清扫现已成为中国侧方淋巴结清扫的主流方案,该术式在明确清扫边界、保护神经功能、彻底清除侧方淋巴结等方面具有明显优势。未来随着更多的高质量侧方淋巴结清扫研究的进行,将会有更多的证据来规范直肠癌侧方淋巴结清扫的临床应用。

Although there is still controversy between the East and the West on lateral lymph node dissection of rectal cancer, Chinese academia has formulated the consensus, guidelines, and norms of lateral lymph node dissection in line with China's national conditions based on the existing evidence-based medicine. Compared with Japan, the lateral lymph node dissection indication in China is more strict, and only when there is clear imaging evidence suspected of lateral metastatic lymph nodes will selective dissection be carried out. The routine dissection area is also limited to the internal ilium and around the obturator. Based on a comprehensive understanding of the anatomical structure of the pelvis, fascia-guided clearance of the two spaces has become the mainstream scheme of lateral lymph node dissection in China. This operation has obvious advantages in clear lymph node dissection boundary, protection of nerve function, complete removal of lateral lymph nodes, and so on. In the future, with the progress of more high-quality lateral lymph node dissection studies, there will be more evidence to regulate the clinical application of lateral lymph node dissection for rectal cancer.

图1 第9版日本《大肠癌处理规约》直肠癌侧方淋巴结转移途径2,(即图中绿色所标记区域No.260、No.270、No.280、No.263d、No.263p、No.273、No.283、No.293淋巴结)
表1 各国指南推荐侧方淋巴结处理方式
[9]
Kim TG, Park W, Choi DH, et al. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients[J]. Int J Colorectal Dis, 2014, 29(2): 193-200.
[10]
Moriya Y, Sugihara K, Akasu T, et al. Patterns of recurrence after nerve-sparing surgery for rectal adenocarcinoma with special reference to loco-regional recurrence[J]. Dis Colon Rectum, 1995, 38(11): 1162-1168.
[11]
Hojo K, Vernava AM3rd, Sugihara K, et al. Preservation of urine voiding and sexual function after rectal cancer surgery[J]. Dis Colon Rectum, 1991, 34(7): 532-539.
[12]
中国医师协会内镜医师分会腹腔镜外科专业委员会, 中国医师协会结直肠肿瘤专业委员会腹腔镜专业委员会, 中华医学会外科学分会结直肠外科学组. 中国直肠癌侧方淋巴结转移诊疗专家共识(2019版) [J]. 中华胃肠外科杂志, 2019, 22(10): 901-912.
[13]
中华人民共和国国家卫生健康委员会医政医管局, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2020年版)[J]. 中国实用外科杂志, 2020, 40(6): 601-625.
[14]
中国抗癌协会, 中国抗癌协会大肠癌专业委员会. 中国恶性肿瘤整合诊治指南-直肠癌部分[J/OL]. 中华结直肠疾病电子杂志, 2022, 11(2): 89-103.
[15]
Ishihara S, Kawai K, Tanaka T, et al. Oncological outcomes of lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy[J]. Dis Colon Rectum, 2017, 60(5): 469-476.
[16]
Akiyoshi T, Ueno M, Matsueda K, et al. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging[J]. Ann Surg Oncol, 2014, 21(1): 189-196.
[17]
Akiyoshi T, Matsueda K, Hiratsuka M, et al. Indications for lateral pelvic lymph node dissection based on magnetic resonance imaging before and after preoperative chemoradiotherapy in patients with advanced low-rectal cancer[J]. Ann Surg Oncol, 2015, 22(Suppl 3): S614-S620.
[18]
Ogawa S, Hida J, Ike H, et al. Selection of lymph node-positive cases based on perirectal and lateral pelvic lymph nodes using magnetic resonance imaging: study of the Japanese society for cancer of the colon and rectum[J]. Ann Surg Oncol, 2016, 23(4): 1187-1194.
[19]
Kim DJ, Chung JJ, Yu JS, et al. Evaluation of lateral pelvic nodes in patients with advanced rectal cancer[J]. AJR Am J Roentgenol, 2014, 202(6): 1245-1255.
[20]
王治杰, 刘正, 梁建伟, 等. 筋膜导向与血管导向解剖入路行直肠癌侧方淋巴结清扫的疗效对比分析[J]. 中华胃肠外科杂志, 2021, 24(7): 611-618.
[21]
刘骞, 王锡山. 筋膜导向在低位直肠癌侧方淋巴结清扫中的应用价值[J]. 中华胃肠外科杂志, 2019, 22(5): 432-435.
[1]
Canessa CE, Badía F, Fierro S, et al. Anatomic study of the lymph nodes of the mesorectum[J]. Dis Colon Rectum, 2001, 44(9): 1333-1336.
[2]
大腸癌研究會. 大腸癌取扱い規約[M]. 9版. 東京: 金原出版株式會社, 2018.
[3]
Du P, Burke JP, Khoury W, et al. Factors associated with the location of local rectal cancer recurrence and predictors of survival[J]. Int J Colorectal Dis, 2016, 31(4): 825-832.
[4]
Monson JR, Weiser MR, Buie WD, et al. Practice parameters for the management of rectal cancer (revised)[J]. Dis Colon Rectum, 2013, 56(5): 535-550.
[5]
Ueno H, Mochizuki H, Hashiguchi Y, et al. Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection[J]. Ann Surg, 2007, 245(1): 80-87.
[6]
Fujita S, Mizusawa J, Kanemitsu Y, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial[J]. Ann Surg, 2017, 266(2): 201-207.
[7]
Peacock O, Chang GJ. The landmark series: management of lateral lymph nodes in locally advanced rectal cancer[J]. Ann Surg Oncol, 2020, 27(8): 2723-2731.
[8]
Ogura A, Konishi T, Cunningham C, et al. Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer[J]. J Clin Oncol, 2019, 37(1): 33-43.
[1] 李卫民, 陈军民, 黄艳丽, 范晓芳, 韩文, 贾磊, 张俊超, 瞿辰. 基于中国甲状腺超声报告与数据系统分析超声在不同大小甲状腺结节中的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(07): 743-748.
[2] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[3] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[4] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[5] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[6] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[7] 付振保, 曹万龙, 刘富红. 腹腔镜直肠癌低位前切除术中不同缝合方法的回肠双腔造口术临床效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 684-687.
[8] 贺亮, 王松林, 周业江. 两种预防性回肠造口在腹腔镜ISR术治疗超低位直肠癌的效果对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 697-700.
[9] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[10] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[11] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
[12] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[13] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[14] 杨红杰, 张智春, 孙轶. 直肠癌淋巴结转移诊断研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 512-518.
[15] 马慧颖, 凡新苓, 覃仕瑞, 陈佳赟, 曹莹, 徐源, 金晶, 唐源. 磁共振加速器治疗局部晚期直肠癌的初步经验[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 519-523.
阅读次数
全文


摘要